DIOCLES
Discrete bIOimaging perCeption for Longitudinal Organ modElling and computEr-aided diagnosiS
| Coordinatore | ECOLE CENTRALE DES ARTS ET MANUFACTURES
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | France [FR] |
| Totale costo | 1˙500˙000 € |
| EC contributo | 1˙500˙000 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | ERC-2010-StG_20091028 |
| Funding Scheme | ERC-SG |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-09-01 - 2016-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ECOLE CENTRALE DES ARTS ET MANUFACTURES
Organization address
address: GRANDE VOIE DES VIGNES contact info |
FR (CHATENAY MALABRY) | hostInstitution | 1˙500˙000.00 |
| 2 |
ECOLE CENTRALE DES ARTS ET MANUFACTURES
Organization address
address: GRANDE VOIE DES VIGNES contact info |
FR (CHATENAY MALABRY) | hostInstitution | 1˙500˙000.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Recent hardware developments from the medical device manufacturers have made possible non-invasive/in-vivo acquisition of anatomical and physiological measurements. One can cite numerous emerging modalities (e.g. PET, fMRI, DTI). The nature (3D/multi-phase/vectorial) and the volume of this data make impossible in practice their interpretation from humans. On the other hand, these modalities can be used for early screening, therapeutic strategies evaluation as well as evaluating bio-markers for drugs development. Despite enormous progress made on the field of biomedical image analysis still a huge gap exists between clinical research and clinical use. The aim of this proposal is three-fold. First we would like to introduce a novel biomedical image perception framework for clinical use towards disease screening and drug evaluation. Such a framework is expected to be modular (can be used in various clinical settings), computationally efficient (would not require specialized hardware), and can provide a quantitative and qualitative anatomo-pathological indices. Second, leverage progress made on the field of machine learning along with novel, efficient, compact representation of clinical bio-markers toward computer aided diagnosis. Last, using these emerging multi-dimensional signals, we would like to perform longitudinal modelling and understanding the effects of aging to a number of organs and diseases that do not present pre-disease indicators such as brain neurological diseases, muscular diseases, certain forms of cancer, etc.
Such a challenging and pioneering effort lies on the interface of medicine (clinical context), biomedical imaging (choice of signals/modalities), machine learning (manifold representations of heterogeneous multivariate variables), discrete optimization (computationally efficient inference of higher-order models), and bio-medical image inference (measurement extraction and multi-modal fusion of heterogeneous information sources).'